+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Left Atrial Appendage Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 56 Pages
  • March 2024
  • Region: Global
  • GlobalData
  • ID: 5955148
The analyst's Medical Devices sector report, “Left Atrial Appendage Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Left Atrial Appendage Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Left Atrial Appendage Closure Device prevents blood flow into the left atrial appendage, preventing blood clotting or pooling.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Left Atrial Appendage Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Left Atrial Appendage Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to :

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Left Atrial Appendage Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
  • 1.1 List of Tables
  • 1.2 List of Figure
2 Introduction
  • 2.1 Left Atrial Appendage Closure Devices Overview
3 Products under Development
  • 3.1 Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
  • 3.2 Left Atrial Appendage Closure Devices - Pipeline Products by Territory
  • 3.3 Left Atrial Appendage Closure Devices - Pipeline Products by Regulatory Path
  • 3.4 Left Atrial Appendage Closure Devices - Pipeline Products by Estimated Approval Date
  • 3.5 Left Atrial Appendage Closure Devices - Ongoing Clinical Trials
4 Left Atrial Appendage Closure Devices - Pipeline Products under Development by Companies
  • 4.1 Left Atrial Appendage Closure Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
5 Left Atrial Appendage Closure Devices Companies and Product Overview
  • 5.1 Abbott Medical Company Overview
  • 5.1.1 Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Aegis Medical Innovations Inc. Company Overview
  • 5.2.1 Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Append Medical Company Overview
  • 5.3.1 Append Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 AuriGen Medical Ltd Company Overview
  • 5.4.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Boston Scientific Corp Company Overview
  • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Conformal Medical Inc Company Overview
  • 5.6.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Cor Habere Corp Company Overview
  • 5.7.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Hangzhou Denuo Electrophysiology Medical Technology Co Ltd Company Overview
  • 5.8.1 Hangzhou Denuo Electrophysiology Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Hansen Medical Inc (Inactive) Company Overview
  • 5.9.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Jenscare Scientific Co Ltd Company Overview
  • 5.10.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Johnson & Johnson Company Overview
  • 5.11.1 Johnson & Johnson Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
  • 5.12.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.13.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 LuSeed Vascular Company Overview
  • 5.14.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Mayo Clinic Company Overview
  • 5.15.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Medtronic Plc Company Overview
  • 5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Northwestern University Company Overview
  • 5.17.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 SentreHEART Inc Company Overview
  • 5.18.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Shanghai Shenqi Medical Technology Co Ltd Company Overview
  • 5.19.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 The Chaim Sheba Medical Center Company Overview
  • 5.20.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
6 Left Atrial Appendage Closure Devices- Recent Developments
7 Appendix
  • 7.1 Methodology
  • 7.2 About the Publisher
  • 7.3 Contact the Publisher
  • 7.4 Disclaimer
List of Tables
  • Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
  • Left Atrial Appendage Closure Devices - Pipeline Products by Territory
  • Left Atrial Appendage Closure Devices - Pipeline Products by Regulatory Path
  • Left Atrial Appendage Closure Devices - Pipeline Products by Estimated Approval Date
  • Left Atrial Appendage Closure Devices - Ongoing Clinical Trials
  • Left Atrial Appendage Closure Devices Companies - Pipeline Products by Stage of Development
  • Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
  • Glossary
List of Figure
  • Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
  • Left Atrial Appendage Closure Devices - Pipeline Products by Territory
  • Left Atrial Appendage Closure Devices - Pipeline Products by Regulatory Path
  • Left Atrial Appendage Closure Devices - Pipeline Products by Estimated Approval Date
  • Left Atrial Appendage Closure Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Medical
  • Aegis Medical Innovations Inc.
  • Append Medical
  • AuriGen Medical Ltd
  • Boston Scientific Corp
  • Conformal Medical Inc
  • Cor Habere Corp
  • Hangzhou Denuo Electrophysiology Medical Technology Co Ltd
  • Hansen Medical Inc (Inactive)
  • Jenscare Scientific Co Ltd
  • Johnson & Johnson
  • Lepu Scientech Medical Technology (Shanghai) Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • LuSeed Vascular
  • Mayo Clinic
  • Medtronic Plc
  • Northwestern University
  • SentreHEART Inc
  • Shanghai Shenqi Medical Technology Co Ltd
  • The Chaim Sheba Medical Center